SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Mankind Pharma informs about outcome of board meeting

10 Feb 2025 Evaluate
Mankind Pharma has informed that the Board appointed Committee of Independent Directors in its meeting held today, February 10, 2025 approved the sale of entire stake held by the Company in Mahananda Spa and Resorts (Mahananda), a Wholly Owned Subsidiary Company to Chalet Hotels Limited. The proceeds of monetization of non-core assets to be utilized to retire part of its debts. The detailed disclosure required as per Regulation 30 of the Listing Regulations read with Master Circular No. SEBI/HO/CFD/ PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure-I. The meeting of the Committee commenced at 4:00 pm (IST) and concluded at 4:25pm (IST).

The above information is a part of company’s filings submitted to BSE.

Mankind Pharma Share Price

2123.20 18.50 (0.88%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×